Effect of hyperhomocysteinemia on the protein kinase DYRK1A in liver of mice

Biochemical and Biophysical Research Communications

Volumn 378, Issue 3, 2009, Pages 673-677

  Hamelet, Julien ^a   Noll, Christophe ^a   Ripoll, Clémentine ^a   Paul, Jean Louis ^b,c   Janel, Nathalie ^a   Delabar, Jean Maurice ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Calpains; Cystathionine beta synthase; DYRK1A; Homocysteine; Mice

Indexed keywords

CALPAIN; CALPASTATIN; DYRK1A ENZYME; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; HYPERHOMOCYSTEINEMIA; KUPFFER CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CALPAIN; COCULTURE TECHNIQUES; CYSTATHIONINE BETA-SYNTHASE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; GLYCOPROTEINS; HEPATOCYTES; HYPERHOMOCYSTEINEMIA; KUPFFER CELLS; LIVER; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES;

MURINAE; MUS;

EID: 57749175510     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.126     Document Type: Article

References (30)

1. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 19 (1999) 217-246
2. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338 (1998) 1042-1050
3. Mudd S.H., Levy H.L., and Kraus J.P. Disorders of transsulfuration. In: Scriver C.R., Beauder A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eighth ed. (2001), McGraw Hill Inc., New York 2007-2056
4. Klatskin G., and Conn H.O. Hepatic lesions in disorders of protein and amino acid metabolism. Histopathology of the Liver (1993), Oxford University Press, New York 241-245
5. Watanabe M., Osada J., Aratani Y., Kluckman K., Reddick R., Malinow M.R., et al. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 92 (1995) 1585-1589
6. Robert K., Nehme J., Bourdon E., Pivert G., Friguet B., Delcayre C., et al. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 128 (2005) 1405-1415
7. Robert K., Pagès C., Ledru A., Delabar J., Caboche J., and Janel N. Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 133 (2005) 925-935
8. Hamelet J., Demuth K., Delabar J.M., and Janel N. Inhibition of extracellular signal regulated-kinase in liver of hyperhomocysteinemic mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 126-127
9. Becker W., and Joost H.G. Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity?. Pro. Nucleic Acid Res. Mol. Biol. 62 (1999) 1-17
10. Maenz B., Hekerman P., Vela E.M., Galcera J., and Becker W. Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1. BMC Mol. Biol. 26 (2008) 9-30
11. Chang H.S., Lin C.H., Yang C.H., Yen M.S., Lai C.R., Chen Y.R., et al. Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis. Int. J. Cancer 120 (2007) 2377-2385
12. Kelly P.A., and Rahmani Z. DYRK1A enhances the mitogen-activated protein kinase cascade in PC12 cells by forming a complex with Ras, B-Raf, and MEK1. Mol. Biol. Cell 16 (2005) 3562-3573
13. Fortin L.J., and Genest J. Measurement of homocyst(e)ine in the prediction of atherosclerosis. Clin. Biochem. 28 (1995) 155-162
14. Cai P., Kaphalia B.S., and Ansari G.A. Methyl palmitate: inhibitor of phagocytosis in primary rat Kupffer cells. Toxicology 210 (2005) 197-204
15. Robert K., Chasse J.F., Santiard-Baron D., Vayssettes C., Chabli A., Aupetit J., et al. Altered gene expression in liver from a murine model of hyperhomocysteinemia. J. Biol. Chem. 278 (2003) 31504-31511
16. Tichopad A., Dilger M., Schwarz G., and Pfaffl M.W. Standardized determination of real-time PCR efficiency from a single reaction set-up. Nucleic Acids Res. 31 (2003) e122
17. Kohli V., Gao W., Camargo C.A., and Clavien P.A. Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc. Natl. Acad. Sci. USA 94 (1997) 9354-9359
18. Woods Y.L., Rena G., Morrice N., Barthel A., Becker W., Guo S., et al. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 355 (2001) 597-607
19. Branchi I., Bichler Z., Minghetti L., Delabar J.M., Malchiodi-Albedi F., Gonzalez M.C., et al. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. J. Neuropathol. Exp. Neurol. 63 (2004) 429-440
20. Zhang H.S., Cao E.H., and Qin J.F. Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway. Pharmacology 74 (2005) 57-64
21. Moshal K.S., Sen U., Tyagi N., Ovechkin A.V., Kartha G.K., and Tyagi S.C. Homocysteine alters redox regulation through thioredoxin-interacting protein: a novel role of forkhead transcription factor (FOXO-3a/FKHR-L1). FASEB J. 20 (2006) A1456-A1457
22. Likogianni V., Janel N., Ledru A., Beaune P., Paul J.L., and Demuth K. Thiol compounds metabolism in mice, rats and humans: comparative study and potential explanation of rodents protection against vascular diseases. Clin. Chim. Acta 372 (2006) 140-146
23. Lochhead P.A., Sibbet G., Morrice N., and Cleghon V. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121 (2005) 925-936
24. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., and Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103 (2001) 2717-2723
25. Postea O., Krotz F., Henger A., Keller C., and Weiss N. Stereospecific and redox-sensitive increase in monocyte adhesion to endothelial cells by homocysteine. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 508-513
26. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12 (1992) 279-298
27. Adayev T., Chen-Hwang M.C., Murakami N., Lee E., Bolton D.C., and Hwang Y.W. Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro. Biochemistry 46 (2007) 7614-7624
28. Spencer M.L., Theodosiou M., and Noonan D.J. NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif. J. Biol. Chem. 279 (2004) 37069-37078
29. Shumway S.D., Maki M., and Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J. Biol. Chem. 274 (1999) 30874-30881
30. Moshal K.S., Singh M., Sen U., Rosenberger D.S., Henderson B., Tyagi N., et al. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H2825-H2835